-
effectivehealthcare.ahrq.gov/products/cognitive-decline/research-protocol
March 23, 2016 - Additionally, dementia-related expenses exceed those for other diseases, including heart disease and cancer … associated with an increased risk of developing MCI and Alzheimer's disease, including depression, cancer … -
Social engagement
Network, social activities
Vitamin supplements
Multivitamins, vitamin D … D. … Atkins D, Chang S, Gartlehner G, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/behavior-change_research.pdf
August 01, 2015 - Key Informants
Appendix D. … published, strength of evidence methodology for qualitative research, CerQUAL, was
presented at a recent GRADE … Enhancing the use and quality of colorectal
cancer screening. … 1
Appendix D. … D-2
Interview Guide
1.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
May 08, 2013 - Research Review Citation: Chou R, Dana T, Bougatsos C, Blazina I, Starmer A, Reitel K,
Buckley D. … The NPUAP has
now adopted the term "Stage" rather than "Grade". … The first
(BMJ) is listed in Appendix D as excluded because ""Wrong
Population"". … Also there is no grade V. … evaluation of screening tools,
distinguishes between screening for disease detection such as
breast cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
March 11, 2010 - history of thyroid disease, Down’s syndrome and treatment with
external beam radiation for head and neck cancer … Chest pain
d. Increased blood pressure
e. Anxiety
f. Depression
g. Insomnia
h. Nausea
i. … Abnormal hair loss
d. Upset stomach or nausea
e. Loss of taste or metallic taste
f. … Interventions
(dose, duration) , Control, Outcomes assessed/when assessed, Adverse effects, Results
D. … In: Fauci A, Braunwald E,
Kasper D, Houser S, Longo D, Jameson J, editors.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/plant-based-chronic-pain-review-q2.pdf
May 01, 2021 - Dowell D, Haegerich TM, Chou R. … Dowell D, Haegerich TM, Chou R. … D-1
Appendix D. Literature Flow Diagram
Figure D-1. … Takakuwa KM, Sulak D. … Yassin M, Oron A, Robinson D.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
January 01, 2007 - renal artery aneurysm requiring repair, aortic disease requiring invasive
intervention, or concurrent cancer … Only RCTs could receive an A
grade. … Hanzel G, Balon H, Wong O, Soffer D, Lee DT,
Safian RD. … Harjai K, Khosla S, Shaw D et al. … Ramos F, Kotliar C, Alvarez D et al.
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician
February 16, 2016 - Owens DK, Lohr KN, Atkins D, et al. … Oral: 666 mg (two 333-mg tablets) 3 times per day
Modulates hyperactive glutamatergic n-methyl-d-aspartate … consistently related heavy alcohol consumption to an increased risk of serious health problems such as cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
February 01, 2016 - * Owens DK, Lohr KN, Atkins D, et al. … Oral: 666 mg (two
333-mg tablets) 3
times per day
Modulates hyperactive glutamatergic
n-methyl-d-aspartate … consistently
related heavy alcohol consumption to an increased risk of
serious health problems such as cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/plant-based-chronic-pain-review-jan-2020.pdf
January 01, 2020 - Dowell D, Haegerich TM, Chou R. … Dowell D, Haegerich TM, Chou R. … Turcotte D, Doupe M, Torabi M, et al. … D-1
Appendix D. Literature Flow Diagram
Figure D-1. … Yassin M, Oron A, Robinson D.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_disposition-comments.pdf
January 01, 2020 - 3 pain
In Bhatla, 2010, 20.5% of the HPV group and 4.0%
of the placebo group reported Grade 3 pain … The table results
reflect death categorized as noncardiovasuclar, cancer
and other. … TEP # 4 Executive
Summary—
Results, Table
D (and Table
32), Page 21,
line 22
Table D (and Table … Does grade refer to the
severity rating system described in the methods? … In J Gyn Cancer. 2008;18:1013-9
Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland
A, Izurieta
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
January 01, 2020 - 3 pain
In Bhatla, 2010, 20.5% of the HPV group and 4.0%
of the placebo group reported Grade 3 pain … The table results
reflect death categorized as noncardiovasuclar, cancer
and other. … TEP # 4 Executive
Summary—
Results, Table
D (and Table
32), Page 21,
line 22
Table D (and Table … Does grade refer to the
severity rating system described in the methods? … In J Gyn Cancer. 2008;18:1013-9
Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland
A, Izurieta
-
effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/research-protocol
April 02, 2015 - For healthy adults, AIs for ALA are 1.1 g/d for females and 1.6 g/d for males. 16 After evaluating evidence … attacks)
Exclude populations chosen for having a non-CVD or non-diabetes-related disease (e.g., cancer … D. … Grading the Strength of Evidence
We will grade the strength of the body of evidence as per the AHRQ … FAs and different populations [healthy, at risk, and with CVD])
Outcome
Strength of Evidence Grade
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/preoperative-testing_executive.pdf
January 01, 2014 - find some abnormal test results that will lead
to new diagnoses (such as previously undetected lung
cancer … a
n
d
s
tr
en
g
th
o
f
ev
id
en
ce
O
u
tc
o
m
e
Su
rg
er
y
Te
st
s
St
u
d
y
D
es
ig … s
St
u
d
y
D
es
ig
n
(R
is
k
o
f
B
ia
s)
Fi
n
d
in
g
St
re
n
g
th
o
f
Ev
id
en
ce … s
St
u
d
y
D
es
ig
n
(R
is
k
o
f
B
ia
s)
Fi
n
d
in
g
St
re
n
g
th
o
f
Ev
id
en
ce … (
1
hi
gh
)
N
o
si
gn
ifi
ca
nt
d
if
fe
re
nc
e
in
p
ro
ce
du
re
d
el
ay
.
-
effectivehealthcare.ahrq.gov/sites/default/files/introduction.ppt
January 01, 2010 - References:
Slutsky J, Atkins D, Chang S, et al. … Slutsky J, Atkins D, Chang S, et al. … quality of individual studies
Assess applicability
Present findings
Synthesize quantitative data
Grade … References
References
Slutsky J, Atkins D, Chang S, et al. … Slutsky J, Atkins D, Chang S, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/introduction.ppt
January 01, 2010 - References:
Slutsky J, Atkins D, Chang S, et al. … Slutsky J, Atkins D, Chang S, et al. … quality of individual studies
Assess applicability
Present findings
Synthesize quantitative data
Grade … References
References
Slutsky J, Atkins D, Chang S, et al. … Slutsky J, Atkins D, Chang S, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-approaches_research.pdf
June 01, 2011 - the study is not a
mega-trial) precluding an answer to the Key Question (resulting in an evidence grade … Survival
of cancer patients treated with mistletoe
extract (Iscador): a systematic literature
review … BMC Cancer 2009;9:451. PMID:
20021637
9. Abbas S, Seitz M. … self-regulation from
published prospective controlled cohort
studies for long-term therapy of breast
cancer … non-randomized
comparative studies of the short-term
outcomes of laparoscopic resection for
colorectal cancer
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
June 01, 2012 - Studies
Analyze and Synthesize Studies
Assess Risk of Bias as a Domain of Quality
Assess Applicability
Grade … Screening for Cervical Cancer. … results to treatment not reported
Order of testing varies across subjects and was not randomly assigned D-dimer … Screening for Cervical Cancer. … likely to have false-positive screenings under current recommendations because of the risks of high-grade
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
June 01, 2012 - Studies
Analyze and Synthesize Studies
Assess Risk of Bias as a Domain of Quality
Assess Applicability
Grade … Screening for Cervical Cancer. … results to treatment not reported
Order of testing varies across subjects and was not randomly assigned D-dimer … Screening for Cervical Cancer. … likely to have false-positive screenings under current recommendations because of the risks of high-grade
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1512.pdf
December 01, 2015 - cardiometabolic syndrome, hypertension, stroke,
sleep apnea, osteoarthritis, gall bladder disease, and some cancers … , grade II at 62.12%, and grade III at 51.44%, (p<0.0001). … However, no link between liraglutide and
thyroid C-cell tumors, including a thyroid cancer called medullary … used in patients with a
personal or family history of MTC or in patients with multiple endocrine neoplasia … Wilding J, Lau D, Astrup A, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ischemic-stroke-treatment_research-protocol.pdf
February 19, 2010 - of Ischemic Stroke
Stroke is the third leading cause of death following diseases of the heart and cancer … Effectiveness outcomes will include: recanalization as measured by post-TIMI flow grade
(0/1=no recanalization … D. … Lloyd-Jones D, Adams R, Carnethon M et al. … Thrombectomy
N/A
TriSpan Endovascular Thrombectomy N/A
Phenox GmbH
Lise-Meitner-Allee 31
D-